摘要
目的:探讨高危型HPV感染CIN患者的治疗方法,为高危型HPV感染CIN患者的早期治疗寻求新途径。方法:对2006年3月至2010年6月在我院诊断的高危型HPV感染的CIN患者140例进行随机分组后治疗,分为LEEP联合保妇康栓组、LEEP组,治疗后随访2年,复查监测指标,观察每组的治疗效果。结果:LEEP组治疗后6个月、12个月、18个月及2 4个月的高危型HPV清除率分别为80.0%、82.9%、84.3%、92.9%,LEEP联合保妇康栓组的分别为82.9%、94.3%、95.7%、98.6%,2组相比有显著性差异。治疗后2年的宫颈活检结果显示LEEP联合保妇康栓组的CIN率低于LEEP组。结论:LEEP联合保妇康栓治疗可提高高危型HPV感染CIN患者的HPV清除率,降低CIN复发率,优于其他单一治疗方法。
Objective:To investigate the clinical efficacy of LFLEP combined with Baofukang suppository, in the treatment of cervical intraepithelial neoplasia(CIN) patients with high risk human papillomavirus(hr- HPV) infec- tion. Methods:From 2006 March to 2010 June,140 women diagnosed as CIN combined with hr - HPV infection were randomly divided into 2 groups:LEEP + Baofukang suppository group(n=70) and LEEP group (n=70). To observe the monitoring indicators and curative effect in two years after treatment. Results: LEEP group, hr - HPV clearance rates were 80% ,82.9% ,84.3%, 92.9% after treatment for 6 months, 12 months, 18 months and 24 months; in LEEP combined with Baofukang suppository group were 82.9% ,94.3% ,95.7% ,98.6%. The results showed the in- cidence of CIN in LEEP combined with Baofukang suppository, groups were lower than the LEEP group. Conclusion: LEEP combined with Baofukang suppository in the treatment of CIN and hr - HPV infection can improve the HPV re- moval rate and reduce the recurrence rate of CIN,which is better than LEEP group.
出处
《现代肿瘤医学》
CAS
2014年第3期628-630,共3页
Journal of Modern Oncology
基金
西安市未央区科技局(编号:200916)